NCT04959292

Brief Summary

Meniscus injury is common in sports-active population, and partial or total meniscectomy is standard surgery for meniscal tear. Meniscus plays an important role in load transferring, shock absorbing, knee joint stabilizing and chondral protection. Plenty of studies indicate that meniscus-deficiency increases the risk of OA and cause long-term poor outcomes. Spontaneous human meniscus regeneration is rarely reported and whether regenerated meniscus is chondral-protective and can prevent OA progression remain unknown. During our clinical practice, we have encountered many cases with complete meniscal regeneration under arthroscopy. In this study, we will include all the patients who receiving meniscectomy and ACL reconstruction and knee arthroscopy 2 years after primary surgery. Patients demographic characters will be reviewed. The resected meniscus in the primary surgery and biopsied regenerated meniscus will be analyzed by histological and immunohistochemical method and their ultrastructure will be observed by electron microscope. Patients will be followed at 2-, 5- and 10-year after the primary surgery and the cartilage degeneration and OA progression will be assessed.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2020

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

June 16, 2021

Completed
27 days until next milestone

First Posted

Study publicly available on registry

July 13, 2021

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

July 13, 2021

Status Verified

July 1, 2021

Enrollment Period

2.3 years

First QC Date

June 16, 2021

Last Update Submit

July 11, 2021

Conditions

Keywords

meniscusregenerationmeniscectomy

Outcome Measures

Primary Outcomes (1)

  • meniscus regeneration

    the resected meniscus regeneration is found under the arthroscopy.

    2 year

Study Arms (2)

Meniscus regeneration

Reconstruction of the anterior cruciate ligament, total or partial meniscus resection was performed in our hospital, and two years after the operation, the meniscus regeneration was found under secondary arthroscopy.

Diagnostic Test: arthroscopy

Meniscus without regeneration

Anterior cruciate ligament reconstruction, total or partial meniscus resection was performed in our hospital, and two years after the operation, no meniscus regeneration was found under secondary arthroscopy.

Diagnostic Test: arthroscopy

Interventions

arthroscopyDIAGNOSTIC_TEST

arthroscopy

Meniscus regenerationMeniscus without regeneration

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

all the patients receving meniscectomy

You may qualify if:

  • Patients intending to undergo single-knee ACL reconstruction at our Institute of Sports Medicine.
  • The age of 18 \~ 50 years old at the time of operation.
  • Both men and women.
  • BMI \< 24.
  • Complete or partial meniscectomy was performed at the same time as ACL reconstruction.
  • Patients willing to undergo a second arthroscopic exploration 2 years postoperatively and to take the portal screws used to fix the ligaments during the initial surgery.
  • Patients with preserved meniscus video during ACL reconstruction.
  • The degree of knee osteoarthritis (KOA) at the time of operation was \< Ⅲ of Kellgren Laurence level.

You may not qualify if:

  • Patients with severe knee cartilage injury.
  • Patients with KOA≥KLⅢ at the time of operation.
  • The patients cannot be followed up.
  • Patients who refused the second arthroscopy and the removal of the internal fixation portal screw at the time of surgery.
  • Patients with rheumatoid arthritis or other arthritis.
  • Patients with other systemic diseases who take oral anti-inflammatory analgesics for years.
  • Patients with multiple injections of drugs in the joint due to various reasons.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of Sports Medicine, Peking University Third Hospital

Beijing, Beijing Municipality, 100191, China

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

resected meniscus and biopsy of regenerated meniscus

MeSH Terms

Interventions

Arthroscopy

Intervention Hierarchy (Ancestors)

EndoscopyDiagnostic Techniques, SurgicalDiagnostic Techniques and ProceduresDiagnosisMinimally Invasive Surgical ProceduresSurgical Procedures, OperativeOrthopedic Procedures

Study Officials

  • Zimu Mao, Dortor

    Peking University Third Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Zimu Mao, Doctor

CONTACT

Jiakuo Yu, Professor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 16, 2021

First Posted

July 13, 2021

Study Start

June 1, 2020

Primary Completion

September 1, 2022

Study Completion

December 1, 2022

Last Updated

July 13, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will not share

Locations